Importer of Controlled Substances Application: SA INTL GMBH C/O., SIGMA ALDRICH CO., LLC., 32319-32320 [2014-12955]

Agencies

• Drug Enforcement Administration
• Department of Justice

[Federal Register Volume 79, Number 107 (Wednesday, June 4, 2014)]
[Notices]
[Pages 32319-32320]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12955]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: SA INTL GMBH C/O., 
SIGMA ALDRICH CO., LLC.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before July 7, 2014. Such persons may also file a 
written request for a hearing on the application pursuant to 21 CFR 
1301.43 on or before July 7, 2014.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, and dispensers of controlled substances 
(other than final orders in connection with suspension, denial, or 
revocation of registration) has been redelegated to the Deputy 
Assistant Administrator of the DEA Office of Diversion Control 
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR 
part 0, subpart R, App.
    In accordance with 21 CFR 1301.34(a), this is notice that on 
January 8, 2014, SA INTL GMBH C/O., Sigma Aldrich Co., LLC., 3500 
Dekalb Street, St. Louis, Missouri 63118, applied to be registered as 
an importer of the following basic classes narcotic or non-narcotic of 
controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................  I
Mephedrone (1248)...........................  I
N-Ethylamphetamine (1475)...................  I
Aminorex (1585).............................  I
Gamma Hydroxybutyric Acid (2010)............  I
Methaqualone (2565).........................  I
Alpha-ethyltryptamine (7249)................  I
Ibogaine (7260).............................  I
Lysergic acid diethylamide (7315)...........  I
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
Mescaline (7381)............................  I
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
3,4-Methylenedioxyamphetamine (7400)........  I
N-Hydroxy-3,4-methylenedioxyamphetamine       I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)....  I
4-Methoxyamphetamine (7411).................  I
Bufotenine (7433)...........................  I
Diethyltryptamine (7434)....................  I
Dimethyltryptamine (7435)...................  I
Psilocybin (7437)...........................  I
Psilocyn (7438).............................  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)  I
N-Benzylpiperazine (7493)...................  I
MDPV (7535).................................  I
Heroin (9200)...............................  I

[[Page 32320]]

 
Normorphine (9313)..........................  I
Etonitazene (9624)..........................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Methylphenidate (1724)......................  II
Amobarbital (2125)..........................  II
Pentobarbital (2270)........................  II
Secobarbital (2315).........................  II
Glutethimide (2550).........................  II
Nabilone (7379).............................  II
Phencyclidine (7471)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Diphenoxylate (9170)........................  II
Ecgonine (9180).............................  II
Ethylmorphine (9190)........................  II
Hydrocodone (9193)..........................  II
Levorphanol (9220)..........................  II
Meperidine (9230)...........................  II
Methadone (9250)............................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
Opium, powdered (9639)......................  II
Levo-alphacetylmethadol (9648)..............  II
Oxymorphone (9652)..........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis.
    In reference to drug codes 7360 and 7370, the company plans to 
import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No 
other activity for this drug code is authorized for this registration.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (January 25, 
2007).
    In regard to the non-narcotic raw material, any bulk manufacturer 
who is presently, or is applying to be, registered with the DEA to 
manufacture such basic classes of controlled substances listed in 
schedules I or II, which fall under the authority of section 
1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the 
circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 
1316.47.

    Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12955 Filed 6-3-14; 8:45 am]
BILLING CODE 4410-09-P